Health Insurance Innovations, Inc. (NASDAQ:HIIQ)‘s stock had its “buy” rating reissued by Canaccord Genuity in a research report issued to clients and investors on Friday. They currently have a $39.00 target price on the financial services provider’s stock. Canaccord Genuity’s price objective would suggest a potential upside of 25.81% from the company’s current price.

Other equities research analysts also recently issued reports about the company. UBS AG upgraded Health Insurance Innovations to an “outperform” rating in a report on Thursday, May 4th. Raymond James Financial, Inc. upgraded Health Insurance Innovations from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Thursday, May 4th. Zacks Investment Research upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a report on Friday, May 5th. TheStreet upgraded Health Insurance Innovations from a “c” rating to a “b-” rating in a report on Monday, May 22nd. Finally, Craig Hallum initiated coverage on Health Insurance Innovations in a report on Monday, June 12th. They issued a “buy” rating and a $28.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $30.83.

Health Insurance Innovations (NASDAQ:HIIQ) traded down 7.88% during trading on Friday, reaching $31.00. The company had a trading volume of 2,782,471 shares. Health Insurance Innovations has a one year low of $4.00 and a one year high of $35.85. The firm’s 50 day moving average is $30.80 and its 200 day moving average is $22.18. The company has a market capitalization of $386.54 million, a PE ratio of 25.08 and a beta of 0.68.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.13. Health Insurance Innovations had a return on equity of 22.89% and a net margin of 5.56%. The business had revenue of $61.80 million for the quarter, compared to the consensus estimate of $53.69 million. The firm’s revenue for the quarter was up 38.9% on a year-over-year basis. On average, equities research analysts predict that Health Insurance Innovations will post $1.53 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Canaccord Genuity Reaffirms Buy Rating for Health Insurance Innovations, Inc. (HIIQ)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/01/canaccord-genuity-reaffirms-buy-rating-for-health-insurance-innovations-inc-hiiq.html.

In related news, CEO Bruce Telkamp sold 30,000 shares of the stock in a transaction that occurred on Tuesday, July 18th. The stock was sold at an average price of $26.68, for a total value of $800,400.00. Following the transaction, the chief executive officer now owns 104,001 shares of the company’s stock, valued at $2,774,746.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sheldon Wang sold 4,750 shares of the stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $25.80, for a total value of $122,550.00. Following the completion of the transaction, the insider now directly owns 224,001 shares in the company, valued at approximately $5,779,225.80. The disclosure for this sale can be found here. Over the last quarter, insiders sold 194,242 shares of company stock worth $5,088,007. Company insiders own 30.00% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Russell Investments Group Ltd. purchased a new position in shares of Health Insurance Innovations during the second quarter valued at about $14,467,000. Lyon Street Capital LLC purchased a new position in shares of Health Insurance Innovations during the first quarter valued at about $8,772,000. Capital World Investors purchased a new position in shares of Health Insurance Innovations during the second quarter valued at about $11,680,000. Renaissance Technologies LLC boosted its position in shares of Health Insurance Innovations by 68.3% in the second quarter. Renaissance Technologies LLC now owns 1,010,400 shares of the financial services provider’s stock valued at $23,744,000 after buying an additional 410,197 shares during the period. Finally, Cortina Asset Management LLC purchased a new position in shares of Health Insurance Innovations during the first quarter valued at about $5,192,000. 88.96% of the stock is currently owned by institutional investors.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Stock Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related stocks with our FREE daily email newsletter.